Vice Provost and Dean of Research
Showing 1,281-1,300 of 2,458 Results
-
Jin Billy Li
Professor of Genetics
Current Research and Scholarly InterestsThe Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.
-
Lingyin Li
Professor of Biochemistry
BioDr. Li is a professor in the Biochemistry Department and ChEM-H Institute at Stanford. She is also a core investigator of the Arc Institute. Her lab works on understanding biochemical mechanisms of the immunotransmitter cGAMP and harnessing it to treat cancer and autoimmunity. She majored in chemistry at University of Science and Technology of China and graduated with a B. En in 2003. She then trained with Dr. Laura Kiessling, a pioneer in chemical biology, at University of Wisconsin-Madison and graduated with a Ph.D in chemistry in 2010. She obtained her postdoctoral training with Dr. Timothy Mitchison at Harvard Medical School, who introduced her to the field of chemical immunology. She started her lab at Stanford in 2015.
-
Minxing Li
Senior Licensing and Strategic Alliances Manager, Life Sciences, Office of Technology Licensing (OTL)
BioMinxing is a Licensing and Strategic Alliances Manager at Stanford OTL with a focus on life sciences technologies. Since she joined Stanford in 2020, she has been involved in protecting, marketing and licensing of Stanford's intellectual property. She is currently responsible for managing Stanford's alliances with the Parker Institute for Cancer Immunotherapy (PICI), where she works closely with investigators who are part of the PICI network and manages IP and licensing matters under the PICI relationship.
Prior to Stanford, Minxing worked as a consultant at IQVIA, Inc. -
Ron Li
Clinical Associate Professor, Medicine
BioRon Li is a Clinical Associate Professor of Medicine in the Division of Hospital Medicine and Center for Biomedical Informatics Research at Stanford University School of Medicine. As the Medical Informatics Director for Digital Health at Stanford Health Care, he provides medical and informatics direction for the health system's enterprise digital health portfolio, including expanding digital referral networks and virtual care modalities. He is also the founding Medical Director for Stanford Health Care at Home and the co-founder and Director for the Stanford Emerging Applications Lab (SEAL), which helps clinicians and staff build ideas into novel digital products that are prototyped and tested for care delivery at Stanford Health Care.
Ron's academic interests focus on the "delivery science" of new technological capabilities such as digital and artificial intelligence in healthcare and how to design, implement, and evaluate new tech enabled models of care delivery. Ron's work spans across multiple disciplines, including clinical medicine, data science, digital health, information technology, design thinking, process improvement, and implementation science. He has consulted for various companies in the digital health and artificial intelligence space. He is an attending physician on the inpatient medicine teaching service at Stanford Hospital and is the Associate Program Director for the Stanford Clinical Informatics Fellowship. -
Ruijiang Li
Associate Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsMy lab's research is focused on the development of imaging and molecular biomarkers to improve cancer detection, diagnosis, prognostication, and prediction of therapy response. Our ultimate goal is to translate these biomarkers into clinical practice to guide optimal management and therapeutic decisions for precision cancer medicine.
-
Shanjun Li
Steven and Roberta Denning Global Sustainability Professor, Senior Fellow at the Freeman Spogli Institute for International Studies and at the Stanford Institute for Economic Policy Research
BioShanjun Li is the Steven and Roberta Denning Global Sustainability Professor and a Senior Fellow at both the Freeman Spogli Institute for International Studies (FSI) and the Stanford Institute for Economic Policy Research (SIEPR). His research focuses on environmental and energy economics, urban and transportation economics, empirical industrial organization, and the Chinese economy. His recent work examines pressing sustainability challenges and the rapid rise of clean energy industries in China, exploring their global implications to inform evidence-based policymaking.
-
Jiahao Liang
Ph.D. Student in Molecular and Cellular Physiology, admitted Autumn 2020
OTL Intern, Office of Technology Licensing (OTL)BioI'm currently a 6th-year Ph.D. student in Molecular & Cellular Physiology and an intern at the Office of Technology Licensing. I study how the spatial organization and structural conformation of synaptic proteins regulate synaptic transmission.
-
Percy Liang
Associate Professor of Computer Science, Senior Fellow at the Stanford Institute for Human-Centered AI, and Associate Professor, by courtesy, of Statistics
BioPercy Liang is an Associate Professor of Computer Science at Stanford University (B.S. from MIT, 2004; Ph.D. from UC Berkeley, 2011) and the director of the Center for Research on Foundation Models (CRFM). He is currently focused on making foundation models (in particular, language models) more accessible through open-source and understandable through rigorous benchmarking. In the past, he has worked on many topics centered on machine learning and natural language processing, including robustness, interpretability, human interaction, learning theory, grounding, semantics, and reasoning. He is also a strong proponent of reproducibility through the creation of CodaLab Worksheets. His awards include the Presidential Early Career Award for Scientists and Engineers (2019), IJCAI Computers and Thought Award (2016), an NSF CAREER Award (2016), a Sloan Research Fellowship (2015), a Microsoft Research Faculty Fellowship (2014), and paper awards at ACL, EMNLP, ICML, COLT, ISMIR, CHI, UIST, and RSS.
-
Joseph C. Liao
Kathryn Simmons Stamey Professor
Current Research and Scholarly InterestsThe overarching theme of my scholarship is to develop precision diagnostics in imaging and biomarkers to guide the delivery of precision therapy for urological diseases including bladder cancer, urinary tract infections, and kidney stone disease.
-
Ronglih Liao
Douglass M. and Nola Leishman Professor of Cardiovascular Disease
BioDr. Liao is a Professor of Medicine and co-Director of Stanford Cardiac Amyloid Center. The major goal of her research program focuses on understanding the mechanisms that underlie the pathophysiology of heart failure and developing novel treatments to combat this process. Her laboratory has played an international leading role in the study of amyloid light chain (AL) cardiomyopathy, a rare and fatal form of cardiovascular disease. We have described the underlying pathophysiologic basis for amyloid cardiomyopathy and found that the circulating amyloidogenic light chain proteins that characterize this disease directly result in a specific cardiotoxic response. Consequently, our research work has redefined AL cardiomyopathy and has raised new treatment approaches. More recently, her research efforts have expanded to include transthyretin (ATTR) cardiac amyloidosis.
In line with her goal of revealing novel therapeutic strategies for patients with cardiovascular disease, our efforts have also focused on characterizing and harnessing endogenous cardiac regenerative mechanisms. Her laboratory initially demonstrated the therapeutic potential of exogenous primitive muscle cells delivered to the injured heart. This work was among the earliest milestones in the field and served as the basis for an international trial of cell-based therapy. Subsequently, Liao lab identified and characterized a population of cardiac progenitor cells and its relationship and dynamic activity following cardiac injury in the adult heart. Her laboratory aims to reveal the molecular mechanisms regulating the endogenous regenerative capacity of the heart and to harness such repair mechanisms for the treatment of cardiovascular disease. Dr. Liao has lectured extensively on both amyloid cardiomyopathy and stem cell biology, and have maintained a history of independent NIH funding in these areas for more than two decades.
Over the course of her academic career, she has taken the greatest pride in mentoring the next generation of scientists. Dr. Liao has had the privilege to supervise several dozen students, postdoctoral fellows, and junior faculty, many of whom have gone on to independent academic careers at the highest institutions. Her contribution to the advancement of scientific knowledge also includes lecturing at various university and academic institutions as well as at scores of conferences and symposia locally, nationally, and internationally. -
Y. Joyce Liao, MD, PhD
Stanford Medicine Professor of Ophthalmology and Professor of Neurology and Neurological Sciences
Current Research and Scholarly InterestsIschemic optic neuropathy
Stem cell transplantation
Optic neuropathy
Optic neuritis
Eye movement disorders
Reading
Parkinson's disease
Multiple sclerosis -
Leticia Liggett
Industrial Contracts Officer-Floater, Office of Technology Licensing (OTL)
BioLeticia is an Industrial Contracts Officer in Stanford’s Office of Technology Licensing. Before joining Stanford, Leticia was a Research Contract Officer at Indiana University and a Conflict of Interest Analyst at the University of Arizona. She has also practiced as a legal aid attorney. Prior to practicing law, she was an instructor of college writing and literature courses.
Education
Ph.D., Indiana University, Bloomington, English Literature
J.D./LL.M. (Intellectual Property), University of New Hampshire Franklin Pierce School of Law
M.A., Butler University, Literature
B.A., DePauw University, English Literature -
Theresa Lii, M.D., M.S.
Instructor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsEvaluating the analgesic and antidepressant effects of ketamine in humans
-
Michael Lim, M.D.
Stanford Medicine Endowed Chair of the Department of Neurosurgery, Professor of Neurosurgery and, by courtesy, of Radiation Oncology, of Medicine, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences
BioDr. Lim is the Chair of the Department of Neurosurgery and a board-certified neurosurgeon specializing in brain tumors and trigeminal neuralgia.
Dr. Lim’s clinical interests include the treatment of benign and malignant brain tumors, with special interest in gliomas, meningiomas, metastatic tumors, and skull base tumors. Dr. Lim also specializes in surgical treatments for trigeminal neuralgia. During his time at Johns Hopkins, Dr. Lim built one of the largest brain tumor and trigeminal neuralgia practices and utilized the most advanced surgical technologies and techniques for his patients. As a passionate voice for patient experience, he has been recognized by his peers and patients for his integrity and compassionate care, including a Service Excellence Award from HealthNetwork Foundation.
As a mentor, he has garnered numerous teaching awards, including being honored as an outstanding teacher by Johns Hopkins University School of Medicine. He is actively involved in shaping education for neurosurgery and oncology across the United States and around the world. He is the recipient of the prestigious 2023 Abhijit Guha Award in Neuro-Oncology.
Dr. Lim’s research interests focus on harnessing the immune system to fight cancer. His laboratory focuses on understanding mechanisms of immune evasion by cancer cells. He has successfully translated his findings from the laboratory to the clinics and has conducted and led several large national immunotherapy clinical trials for brain tumors.
Dr. Lim’s bibliography contains well over 300 articles on topics such as immunotherapy for glioblastoma, long-term survival of glioma patients treated with stereotactic radiation, and treatment of neuropathic pain. His work has appeared in Science Translational Medicine, Clinical Cancer Research, Lancet Oncology, Nature Immunology, and many more publications. He also has written 20 book chapters and monographs.
Dr. Lim is a world leader in immunotherapy for brain tumors. In addition to being invited world-wide to give lectures and seminars, he has given platform presentations on the topics of immunotherapy for brain tumors, neurosurgical techniques and management of brain tumors at the American Society of Clinical Oncologists, American Academy of Neurological Surgeons, Radiological Society of North America, Annual Symposium on Brain and Spine Metastases, Congress of Neurological Surgeons, and other meetings. In addition, he has served as platform chairman of the CNS session at the American Society for Clinical Oncology conference.
Dr. Lim is a member of the American Society for Clinical Oncology, Congress of Neurological Surgeons, American Association of Neurological Surgeons, and Society for Neuro-Oncology. Dr. Lim served as the program co-chair of the Society for Neuro-Oncology and CNS section of the American Society for Clinical Oncology. He also served on many executive committees, including the Executive Committee for the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.
Trigeminal neuralgia treatment: https://www.youtube.com/watch?v=-n8nvwkwZik
Trigeminal neuralgia patient stories: https://www.youtube.com/watch?v=kClePRPYlQs&t=1s
